Synapsoft logo
AI Insights from Disclosures
Searching...
SyntekaBio,Inc. 226330
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
SyntekaBio,Inc. is a bio venture company established in September 2009 that engages mainly in developing AI drug discovery platform services based on technology that processes three-dimensional protein structure and genomic big data, the most critical elements in new drug development, as well as developing its own drug pipelines. In particular, in 2014, the company gained experience with the supercomputing and big data infrastructure that laid the groundwork for its platform service development, through a supercomputing technology investment from the Electronics and Telecommunications Research Institute (ETRI), a commissioned research project with the Next-Generation Personalized Medicine Genome Project, and participation in the International Cancer Genome Consortium's whole-genome cancer analysis project.
Representative Director Jung Jongseon
Founded September 15, 2009
Corporation Type KOSDAQ
Industry Classification Software publishing
Corporate number 11011-4179457
Business number 105-87-35732
Phone Number 070-7663-0958
Fax Number 02-6280-0984
Company Address 18 Gukjegwahak 17-ro, Yuseong-gu, Daejeon
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant